Introduction: Sulfite oxidase deficiency (SOD) is an autosomal recessive inherited disease usually presenting in the neonatal period with severe neurological symptoms including seizures, often refractory to anticonvulsant therapy, and a rapidly progressive encephalopathy resembling neonatal hypoxic ischemia, with premature death. Most patients develop dislocated ocular lenses. Later or milder presentations of SOD are being reported with increasing frequency. These presentations include neurological regression with loss of previously acquired milestones or movement disorders. Case report: We report a four years old girl presenting with intermittent ataxia and uncoordinated limb movements. A similar episode of ataxia had occurred previously, one year before, with complete neurologic recovery and normal developmental milestones. Bilateral lens dislocation had been recently diagnosed. Cranial MRI demonstrated bilateral globus pallidus enhancement. Low homocysteine was found in plasma and Sulfitest R was positive. Further investigations led to confirmation of isolated sulfite oxidase deficiency with no enzyme activity detected on skin fibroblasts culture. Discussion: This case illustrates the clinical variability of SOD and it is not only atypical but also seems to be the mildest form described so far. The association of ectopia lentis with a movement disorder, even without psychomotor regression, should prompt us to look for this diagnosis.
Introduction
Sulfite oxidase is an enzyme in the terminal pathway of sulfur aminoacid degradation. Isolated sulfite oxidase deficiency (SOD) or deficiency of molybdenum, its cofactor (MoCoD), are autosomal recessive inherited diseases, usually with neonatal onset presenting with seizures often refractory to anticonvulsant therapy, axial hypotonia and limb hypertonicity and a rapidly progressive encephalopathy leading to a state resembling that of neonatal hypoxic ischemia. Most patients develop microcephaly, feeding difficulties and dislocated ocular lenses. A few patients present with a milder late onset form of the disease with dystonia and developmental regression [1-3].
Biochemical features of the isolated form include increased urinary excretion of sulfite, thiosulfate, taurine and S-sulfocysteine and low plasma cystine and homocysteine. Urinary excretion of xanthine and hypoxanthine is normal, and so is uric acid, unlike the combined deficiency of sulfite and xanthine oxidase seen in MoCoD (Fig. 1) [1-3] .
The pathogenesis of neurotoxicity is not completely understood but could comprise the accumulation of glutamate, an excitotoxic neurotransmitter, due to the
